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In animal cells the centrosome is positioned at the cell centre in
close association with the nucleus. The mechanisms responsible
for this are not completely understood. Here, we report the first
characterization of human TBCC-domain containing 1 (TBCCD1),
a protein related to tubulin cofactor C. TBCCD1 localizes at the
centrosome and at the spindle midzone, midbody and basal
bodies of primary and motile cilia. Knockdown of TBCCD1 in
RPE-1 cells caused the dissociation of the centrosome from the
nucleus and disorganization of the Golgi apparatus. TBCCD1-
depleted cells are larger, less efficient in primary cilia assembly
and their migration is slower in wound-healing assays. However,
the major microtubule-nucleating activity of the centrosome is
not affected by TBCCD1 silencing. We propose that TBCCD1 is a
key regulator of centrosome positioning and consequently of
internal cell organization.
Keywords: cell migration; centrosome; Golgi apparatus; primary
cilia; TBCCD1
EMBO reports (2010) 11, 194–200. doi:10.1038/embor.2010.5
INTRODUCTION
The centrosome, the major microtubule (MT)-organizing centre in
animal cells, is a key organelle comprising a pair of centrioles
surrounded by the pericentriolar matrix. By nucleating and
organizing the spatial distribution of MTs in interphase, the
centrosome has been implicated in organelle positioning—for
example, Golgi apparatus (GA)—cell migration, adhesion and
polarity, and in mitosis it assists spindle pole formation (reviewed
in Lu¨ders & Stearns, 2007). The ability to nucleate the ciliary
axoneme, becoming a basal body, constitutes another main role of
the centrosome. Usually, the centrosome is maintained at the cell
centre, closely associated with the nucleus. This has been shown
to be essential, for example, in the early development of
Caenorhabditis elegans (Malone et al, 2003). The centrosome is
repositioned to peripheral sites during cell-state transitions such as
wound healing, cell migration and cell growth and differentiation
(Yvon et al, 2002; de Anda et al, 2005).
The geometrical constraints imposed by the substratum have a
crucial role in centrosome positioning and the internal organization
of the cell (Pouthas et al, 2008), but probably do not provide the sole
answer to this question. The MTs and forces exerted on them by
actomyosin and dynein are also crucial (Wittmann & Waterman-
Storer, 2001; Burakov et al, 2003). A variety of data support the
existence of a physical link between the centrosome and the nuclear
envelope and implicate proteins such as Zyg-12 and Emerin
(Malone et al, 2003; Salpingidou et al, 2007). This interaction
seems to be regulated by the p160ROCK Rho-associated kinase and
the coordinated activity of Polo/Greatwall (Gwl) mitotic kinases
(Chevrier et al, 2002; Archambault et al, 2007).
A dynamic nucleus–centrosome connection also seems imp-
ortant for directed cell migration—for example, in neurons
(Higginbotham & Gleeson, 2007)—and several studies reported
centrosome reorientation towards the leading edge in migrating
cells (Yvon et al, 2002). Nevertheless, this is not true for all cell
types and is also substratum-dependent, leaving the relevance
of this reorientation for cell migration still open to debate
(Yvon et al, 2002).
In recent years, tubulin cofactors (TBC) A–E, which participate
in the tubulin-folding pathway, have emerged as proteins with
crucial roles, not always associated directly to their expected role
in the pathway, but still related to the cytoskeleton. For example,
TBCD is a centrosomal protein required for g-tubulin ring complex
recruitment and mitotic spindle organization (Cunningham
& Kahn, 2008). These data and the fact that specific TBC domains
were identified in the functionally related proteins RP2 and E-like
(Bartolini et al, 2002, 2005), suggest that they could have evolved
to deal with specific requirements of MT assembly and dynamics,
possibly in specific cell types. This prompted us to search the
human genome database for other proteins with TBC-specific
domains. During this process we found TBCC-domain containing
1 (TBCCD1), which is conserved through the phylogenetic tree
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Fig 1 | TBCCD1 sub-cellular localization in human cells. (A) HEK293T cells
were immunostained with antibodies against TBCCD1 and either IFT88 or
poly-glutamylated tubulin. DNA was stained with DAPI. (a) Interphase cell,
(b) cell in metaphase, (c) cell in anaphase, (d) cell in telophase and
(e) cell-cycle-arrested cell after serum starvation for 24 h. The arrowheads
point to TBCCD1 at the centrosomes (a,d), the constriction zone (d)
and the basal body (e). Panels are representative of five independent
experiments. (B) Immunostaining of HeLa and RPE-1 interphase cells
with anti-TBCCD1 showing pericentriolar matrix localization (a,b). RPE-1
cell in anaphase (c). Scale bars, 5mm. Panels are representative of five
independent experiments. (C) Western blot analysis of nuclear and
cytosolic protein fractions (NF and CF) of RPE-1 cells shows that TBCCD1
is mainly present in the nuclear fraction. Results are representative of
three independent experiments. DAPI, 4,6-diamidino-2-phenylindole;
HEK, human embryonic kidney; TBCCD1, TBCC-domain containing 1.
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(Stephan et al, 2007). TBCCD1 is related to TBCC, which, together
with TBCD, acts as a b-tubulin GTPase-activating protein (GAP;
Fontalba et al, 1993; Tian et al, 1999). TBCCD1 is also related to
RP2, which overlaps functionally with TBCC (Bartolini et al,
2002), seeming to participate in tubulin quality control at the basal
body of the Trypanosoma flagellum (Stephan et al, 2007).
Here, we report the first characterization of human TBCCD1
and show that it is required for centrosome and GA perinuclear
positioning in RPE-1 cells. We also show that TBCCD1-silenced
cells are less efficient in primary cilia assembly and affected in
cell migration.
RESULTS AND DISCUSSION
TBCCD1 localizes at the centrosome and basal bodies
In addition to the TBCC domain, TBCC, RP2 and TBCCD1 possess
a CARP domain—a domain found in Cyclase-associated proteins
(CAPs; supplementary Fig S1A,B online)—but their amino-acid
sequence identity is low outside these domains.
Through a yeast complementation assay, we observed TBCCD1
to be unable to complement yeast TBCC (CIN2) deletion (supple-
mentary Fig S1C online). This suggests that, unlike RP2, TBCCD1
does not overlap functionally with TBCC. This could be due to
TBCCD1 lacking the arginine conserved in TBCC and RP2 that is
crucial for their GAP activity towards tubulin (Veltel et al, 2008).
To study the subcellular localization of TBCCD1, a specific
mouse polyclonal anti-TBCCD1 serum was raised (supplementary
Fig S2A,B online) and used to perform immunofluorescence
analysis of human embryonic kidney 293T (HEK293T), HeLa and
RPE-1 cells. With this analysis we observed TBCCD1 to be
localized at the cytoplasm and at the centrosome throughout the
cell cycle (Fig 1A,B). Furthermore, by using HeLa and RPE-1 cells
expressing centrin–green fluorescent protein (GFP) we showed that
TBCCD1 localizes at the pericentriolar matrix (Fig 1B; supplementary
Fig S6A online). TBCCD1 was also observed in the basal body
of primary cilia (Fig 1A; supplementary Fig S4 online). Immuno-
localization in mouse brain primary cultures showed TBCCD1 also
in the basal bodies of motor cilia (supplementary Fig S3A online). The
localization data were supported by the expression of fluorescently
tagged TBCCD1 (supplementary Fig S4 online). Tagged TBCCD1
accumulated at the centrosome during the cell cycle and also at
the spindle midzone and the midbody. However, when using the
antiserum, TBCCD1 was barely detected at the latter two sites—
unless HEK293T cells were transfected with untagged TBCCD1
(supplementary Fig S2C online)—indicating that the endogenous
TBCCD1 levels are too low to be detected or those localizations result
from overexpression.
We also observed that TBCCD1 centrosomal localization is not
affected by MT depolymerization with nocodazole (supplementary Fig
S5A online), indicating it to be an integral centrosome component.
Also, its amino-terminal domain (aa 1–328) is involved in centrosome
targeting (supplementary Fig S5B online). TBCCD1 was detected, with
d-tubulin, mainly in the nuclear fraction of RPE-1 cells (Fig 1C). As
centrosomes are known to fractionate with nuclei, this observation also
supports TBCCD1 centrosomal localization. Finally, reverse transcrip-
tion (RT)–PCR analysis showed that tbccd1was transcribed in all mouse
tissues tested (supplementary Fig S3B online), whereas the protein was
detected effectively in the brain and the testis, the two tissues where
tubulin was more abundant. These results suggest that TBCCD1 might
be regulated post-transcriptionally in the different tissues.
TBCCD1 RNAi affects centrosome and Golgi positioning
To study the function of TBCCD1, the gene was silenced with a
small interfering RNA (siRNA) pool in RPE-1 cells. TBCCD1
silencing was confirmed by RT–PCR, western blotting and
immunolocalization analysis, which showed decreased fluore-
scence intensity at the centrosome and cytoplasm (Fig 2A;
supplementary Fig S6A online). Seventy-two hours after transfec-
tion, the cells treated with the siRNA pool did not become
confluent (supplementary Fig S7A online). Flow cytometry
analysis showed that at 48 h after transfection, TBCCD1-silenced
cells were larger than control cells (Fig 2D) and presented a 14%
increase in the G1 peak and a corresponding decrease in the
number of cells in S phase and G2/M phase (Fig 2D; supplemen-
tary Fig S7B online), suggesting a cell-cycle delay in G1. By using
a g-tubulin antibody to visualize the centrosome, we observed that
TBCCD1 depletion severely affected centrosome localization.
Contrary to control cells where the centrosome is located in the
cell centre and closely associated with the nucleus, in TBCCD1-
depleted cells the centrosome was often located at the cell
periphery (Fig 2Ba). Only 3.3±2.7% of the control population
had the centrosome more than 2 mm away from the nucleus,
whereas in siRNA-treated cells this value rose to 63.5±5.1%
(Fig 2C; supplementary Fig S6C online).
The effect of centrosome displacement in the MT cytoskeleton
was analysed by immunofluorescence, which showed that in
TBCCD1-silenced cells, MTs were still focused on the centrosome
(Fig 2B,b). Next, we analysed MT recovery after depolymerization
with nocodazole in TBCCD1-silenced cells. Similarly to control
cells, the MT aster was visible 5min after nocodazole washout
(supplementary Fig S8 online) and MTs continued to grow from
the centrosome. This showed that misplaced centrosomes were
still able to nucleate MTs and that TBCCD1 is either not necessary
for this centrosome function, or its remaining levels are sufficient.
The ability of displaced centrosomes to assemble primary cilia
was also tested. As confluent cells are more efficient in assembling
primary cilia, more cells were seeded before transfection to obtain
a dense monolayer of siRNA-treated cells. The cells were
retransfected after 48 h and serum-starved. TBCCD1-depleted
cells, under similar density conditions as control cells, were
able to assemble primary cilia even when centrosomes were far
from the nucleus, but the percentage of cells presenting cilia was
lower (30±5.9%) than in control cells (87±4.6%; Fig 3A;
supplementary Fig S6D online). Thus, TBCCD1 depletion affects
the ability of RPE-1 cells to assemble primary cilia.
The MT network is responsible for the internal organization of a
cell, being crucial for organizing and positioning the GA close to
the nucleus (Rios & Bornens, 2003). As expected, by using an
antibody against the centrosome marker IFT88 and GA marker
golgin-97, we observed that in control cells the GA has a perinuclear
position and is organized around the centrosome (Fig 3B;
supplementary Fig S6E online). However, in TBCCD1-silenced cells
the GA was disorganized and appeared to follow the centrosome
or be fragmented and spread out in the cytoplasm (Fig 3B; supple-
mentary Fig S6E online). A similar GA phenotype was observed
during Toxoplasma host invasion, where the centrosome is displaced
from its perinuclear position (Coppens et al, 2006).
Microtubules are important for GA biogenesis as its precursors
are carried by motor proteins towards MT minus ends anchored at
the centrosome (Rios & Bornens, 2003). Thus, the observed GA
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Fig 2 | TBCCD1 knockdown in RPE-1 cells leads to loss of centrosome–nucleus association and cell-cycle delay. (A) Top: reverse transcription–PCR
analysis of tbccd1, tbcc and rp2 expression in control and TBCCD1 siRNA-treated cells. Hprt expression was used as an internal control. Bottom:
western blot analysis of TBCCD1 levels in control and TBCCD1 siRNA-treated cells. TBCCD1 levels decreased by about 65% in TBCCD1-silenced cells.
b-Tubulin was used as loading control. (B) Control and TBCCD1-silenced cells immunostained with (a) anti-g-tubulin, (b) anti-a-tubulin and anti-
IFT88. Scale bars, 5 mm. DNA was stained with DAPI. The arrowheads point to centrosomes. (C) The nuclear edge–centrosome measurement approach
used ImageJ software. The mean percentage of cells (±s.d.) with a centrosome–nucleus distance greater than 2mm is shown (n¼ total number of cells
scored in three independent experiments). Statistical significance was calculated using a t-test. (D) Flow cytometric analysis of cell cycle and size in
control and TBCCD1-depleted cells stained with propidium iodide. All experiments were performed using 72 h post-transfection cells, except for the
flow cytometric analysis, which was performed at 48 h. DAPI, 4,6-diamidino-2-phenylindole; HEK, human embryonic kidney; siRNA, small interfering
RNA; TBCCD1, TBCC-domain containing 1.
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phenotype is probably explained by the displacement of the
centrosome and the MT aster. With time this would lead to
displacement of the GA to the new centrosomal position.
However, the centrosome might not adopt a fixed position after
being uncoupled from the nucleus. To test this hypothesis, we
analysed non-confluent RPE-1 cells expressing centrin–GFP by
live imaging under control and RNA interference (RNAi) condi-
tions. Control cells are highly motile and during their movement
the centrosome is in close association with the nucleus without
adopting a preferential localization in relation to it (supplementary
Fig S9 online and supplementary Movie S1 online). By contrast,
TBCCD1-depleted cells migrate more slowly and the centrosome
tends to lag behind the nucleus, coming close to it as the cell
progresses and the tail retracts (supplementary Fig S9 online and
supplementary Movie S2 online). In RNAi cells, although there is
no increase in centrosome movement, as observed in p160ROCK
silencing (Chevrier et al, 2002), its position relative to the nucleus
changes over time, which could result in GA disorganization.
However, direct involvement of TBCCD1 in GA organization
cannot be excluded, although no apparent TBCCD1 localization
at the GA was observed (supplementary Fig S6E online).
Furthermore, the GA disorganization could be implicated in the
lower efficiency of these cells to assemble primary cilia as GA
proteins have been implicated in developmental problems owing
to defective cilium assembly (reviewed in Barr, 2009).
It is well documented that centrosome and GA positioning are
important for cell polarization and directed cell migration
(Vinogradova et al, 2009). Given the phenotypes described above,
we tested whether TBCCD1 depletion caused defects in directed
cell migration by performing a wound-healing assay. Thus, control
and RNAi cell monolayers, obtained as described for cilia
assembly, were wounded to trigger directional migration of cells
towards the wound. By performing live imaging of wound closing,
we observed that RNAi cells were able to close the wound but
were delayed compared with the controls (Fig 4A; supplementary
Movies S3,S4 online), which is consistent with the previous
observations. The centrosome position relative to the nucleus was
also analysed and showed that in control cells there was no
preferential orientation of the centrosome (Fig 4B,C). However, in
the RNAi population, 48.1±1.7% of the cells had the centrosome
behind the nucleus (Fig 4B,C), which agrees with the observations
made when using migrating isolated cells.
Here, we describe a new human pericentriolar matrix component,
TBCCD1, and show that its depletion in RPE-1 cells severely affects
the centrosome position relative to the nucleus, with profound
consequences on GA organization, cell shape and cell migration.
Many of the proteins that have been implicated in centrosome
perinuclear positioning, such as Zyg-12, Emerin and Samp1, are
nuclear envelope proteins (Malone et al, 2003; Salpingidou et al,
2007; Buch et al, 2009) constituting physical links between the
nucleoskeleton and the centrosome and cytoskeleton. TBCCD1
cellular localization suggests that its involvement in centrosome
nuclear association will be through a different mechanism. As
TBCCD1 contains a TBCC domain, we considered that it could be a
GAP for tubulin. This was not confirmed as it does not complement
the yeast CIN2 deletion. However, the possibility that TBCCD1 is a
GAP cannot be excluded. As observed for the p160ROCK Rho-
associated kinase (Chevrier et al, 2002) and the Polo/Gwl mitotic
kinases (Archambault et al, 2007), it is conceivable that this
TBCCD1 putative regulatory activity might be responsible for the
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described phenotypes. TBCCD1 also possesses a CARP domain—a
characteristic of CAP proteins, which regulate actin polymerization.
Thus, an attractive hypothesis is that TBCCD1 could promote
crosstalk between the centrosome and MT and actin cytoskeletons
that are required for centrosome positioning.
Finally, during review of this paper, Feldman & Marshall (2009)
reported that Chlamydomonas reinhardtii TBCCD1 localizes in centri-
oles and in the region between the two nucleus–centriole connectors
(rhizoplasts). A TBCCD1 insertion mutant showed an altered number
of flagella and affected centriole linkage and positioning, which leads
to defects in spindle orientation. In spite of the differences between the
two models, both studies show TBCCD1 to be a centrosomal protein
important for centrosome–nucleus connection.
METHODS
Cell lines and primary cultures. HEK293T and HeLa-centrin–GFP
cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM), whereas hTERT-RPE-1 and hTERT-RPE-1-centrin–GFP
were grown in DMEM/F12, both supplemented with 10% fetal
bovine serum. Mixed primary cell cultures were obtained from
2-day-old murine dissociated cerebella.
Plasmid construction and transfection. Human tbccd1 entire or
truncated coding sequences were amplified by PCR from testis
cDNA and cloned in mammalian expression vectors (pIC111,
pIC112 and pIC113); yeast expression vector pRS413 (also used
to clone tbcc) and bacterial expression vector pGEX-4T-1
(GE Healthcare, Pittsburgh, PA, USA). The human tbcc coding
sequence was amplified from brain cDNA and cloned in
pRS413. Plasmid transfections used Lipofectamine-2000 (Invitrogen,
Carlsbad, CA, USA).
RNA interference. RPE-1 cells (2 104 cells seeded in 12-well
plates) were transfected with 100 nM of a pool of four siRNAs
directed to TBCCD1 obtained from Dharmacon (ON-TARGETplus
Duplex; Lafayette, CO, USA) and Ambion (Silencer Select siRNAs;
Austin, TX, USA), using Oligofectamine (Invitrogen). As negative
controls, Silencer Select Negative Control 2 siRNA (Ambion) or a
non-target fluorescent control siRNA (siGlo RISC-free siRNA;
Dharmacon) was used.
For MT regrowth assays, MTs were depolymerized with 30 mM
of nocodazole for 40min, then the cells were washed thoroughly
with culture medium and placed in medium at 37 1C to enable
MT repolymerization.
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To induce primary cilia assembly, the cells were seeded at a
2.5-fold higher density. Forty-eight hours after transfection the
cells were retransfected and serum-starved (0.25% serum) for 24h.
A similar strategy was used in wound-healing assays, except for
serum starvation. Twenty-four hours after the second transfection, the
cell monolayer was wounded with a micropipette tip. The cells were
either live-imaged or processed for immunofluorescence.
RT–PCR and western blot analysis. Total RNA samples from
mouse tissues and cell lines were prepared by using the RNeasy
Mini kit (Qiagen, Germantown, MD, USA) followed by cDNA
synthesis by using Superscript II RT (Invitrogen).
Total protein extracts were prepared by using a lysis
buffer containing 50mM 4-(2-hydroxyethyl)-1-piperazineethane
sulphonic acid (HEPES; pH 8), 200mM NaCl, 5mM EDTA,
0.5% NP-40, with protease inhibitors. The cytoplasmic and nuclear
extracts were prepared by lysing the cells with 50mMHEPES (pH 8),
10mM NaCl, 2mM ethylenediamine tetraacetic acid (EDTA),
250ml sucrose and 0.1% NP-40, with protease inhibitors, followed
by centrifugation at 3,000g (10min at 4 1C). The supernatant was
collected as the cytosolic fraction. Nuclei were washed with buffer
without NP-40 and resuspended in 50mM HEPES (pH 8), 400mM
NaCl, 2mM EDTA and 20% glycerol (v/v) with protease inhibitors.
After incubation on ice for 20min the samples were centrifuged at
10,000g (10min at 4 1C). The supernatant was collected as the
nuclear fraction. Equal amounts of nuclear and cytosolic extracts
were analysed.
Antibody generation and immunofluorescence. Human TBCCD1
was expressed as a glutathione-S-transferase fusion in BL21 Rosetta
DE3 cells and purified from inclusion bodies using a standard
protocol. The purified protein was used to immunize Balb/c mice.
For immunofluorescence, the cells were fixed with cold
methanol (10min at 20 1C), blocked with 3% bovine serum
albumin (20min), incubated with the primary antibodies (1 h),
washed and incubated with secondary antibodies (1 h). The
primary and secondary antibodies are listed in the supplementary
information online. The cells were analysed by using a Deltavision
System or with Leica DMRA2 and Zeiss LSM510 confocal
microscopes. Images were analysed with the ImageJ software.
Flow cytometric analysis. Control and TBCCD1-silenced cells were
collected, fixed with ethanol and stained with propidium iodide.
Flow cytometry analysis was performed using a FACSCalibur system.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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